Explore Our Cutting-Edge Molecular Oncology Investigations

State Cancer Institute, Gauhati Medical College introduces the state-of-the-art Molecular Oncology investigation facility, where cutting-edge technology converges with medical expertise to redefine the landscape of cancer diagnostics and treatment. At the forefront of medical innovation, our Molecular Oncology investigation facility boasts a dynamic and comprehensive suite of technologies designed to unravel the mysteries of cancer at the molecular level.

The targeted investigations provide a comprehensive genetic profile, identifying key mutations and alterations for personalized treatment strategies. We empower healthcare professionals to identify cancer at its earliest stages, improving treatment options and patient outcomes. The tests are designed to deliver precision at nominal costs, ensuring affordability without compromising quality and reliability, ensuring data security and compliance.

State Cancer Institute welcomes you to explore the potential of our Cutting-Edge Molecular Oncology investigation facility. Contact us today to wish for more information in the pursuit of precision and progress.

Email: cancerhospitalgmc@gmail.com ; molecularoncologysci@gmail.com

Current Scope of Investigations:

Sl. No.

Target Mutation Sources

(Cancer/Others)

Recommended Target Genes & Types

Detection Methods

1.

Breast/Ovarian/ Stomach/Prostrate

BRCA1 & BRCA2

Real Time PCR detection

2.

Head & Neck

HPV 16 &18

Real Time PCR detection

3.

Cervical

HPV 16 &18

Real Time PCR detection

4.

Lungs Panel

EGFR(18,19,20,21), ALK, ROS1, PIK3CA

Real Time PCR detection

5.

Colorectal Panel

KRAS, NRAS & BRAF

Real Time PCR detection

6.

Nasopharyngeal

EBV Type 1 & Type 2

Real Time PCR detection

7.

From any source of Solid Tumors

TP53/P53

Gradient PCR & Gel Documentation

8.

Gliomas

IDH1 & IDH2

Real Time PCR detection

9.

Gliomas

MGMT Promoter Methylation

Real Time PCR detection

10.

Routine DPYD enzyme mutation testing prior to receive chemotherapy

DPYD

(DPYD 2A* allele,13* allele, SNP c.2846A>T, and HapB3)

Real Time PCR detection

11.

Coagulation/Thrombophilia Q panel

Factor II, Factor V Leiden, MTHFR (C677T & A1298C)

Real Time PCR detection

Glimpse of the Molecular Oncology Laboratory, State Cancer Institute: